Furthermore, after two stimulations, L17 CAR-T cells proliferated, and retained their killing activity for CD19+ tumor cells but with less potential for cytokine production in comparison to similarly stimulated 35-G01-L CAR-T cells (Supplementary Fig. 7). Here, CD19 is linked to neoplasm.